You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Therapeutic advances in leiomyosarcoma
|
---|---|
Published in |
Frontiers in oncology, March 2023
|
DOI | 10.3389/fonc.2023.1149106 |
Pubmed ID | |
Authors |
Kristine Lacuna, Sminu Bose, Matthew Ingham, Gary Schwartz |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 50% |
Mexico | 1 | 10% |
Canada | 1 | 10% |
Switzerland | 1 | 10% |
Unknown | 2 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 60% |
Practitioners (doctors, other healthcare professionals) | 2 | 20% |
Science communicators (journalists, bloggers, editors) | 1 | 10% |
Scientists | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 27 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 3 | 11% |
Student > Ph. D. Student | 3 | 11% |
Student > Bachelor | 2 | 7% |
Student > Doctoral Student | 1 | 4% |
Lecturer > Senior Lecturer | 1 | 4% |
Other | 2 | 7% |
Unknown | 15 | 56% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 19% |
Unspecified | 3 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 7% |
Biochemistry, Genetics and Molecular Biology | 2 | 7% |
Nursing and Health Professions | 1 | 4% |
Other | 0 | 0% |
Unknown | 14 | 52% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2024.
All research outputs
#5,170,135
of 25,418,993 outputs
Outputs from Frontiers in oncology
#1,770
of 22,490 outputs
Outputs of similar age
#99,928
of 423,868 outputs
Outputs of similar age from Frontiers in oncology
#57
of 1,388 outputs
Altmetric has tracked 25,418,993 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,490 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,868 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 1,388 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.